GNH USA

Europe — EMA

Oxaliplatin Accord

Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a platinum compound presented as a unknown/unknown for intravenous use. It treats colorectal cancer and may be used in other oncology settings.

Request sourcing

1
Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a platinum compound presented as a unknown/unknown for intravenous use. It treats colorectal cancer and may be used in other oncology settings.

GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier of hospitals and oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Accord ... ... ... ... ... ... ... ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Oxaliplatin
Route
Intravenous Use
Manufacturer
Accord Healthcare Polska Sp. Z O.O.
Origin
EU

Related products